Literature DB >> 30177259

Graves' orbitopathy: Diagnosis and treatment.

Delphine Drui1, Laurence Du Pasquier Fediaevski2, Catherine Vignal Clermont3, Chantal Daumerie4.   

Abstract

Entities:  

Keywords:  Chirurgie ophtalmologique; Corticotherapy; Corticothérapie; EUGOGO; Graves’ orbitopathy; Immunosuppression treatment; Orbitopathie basedowienne; Smoking; Tabac; Traitement immunosuppresseur

Mesh：

Substances：

Year:  2018        PMID： 30177259     DOI： 10.1016/j.ando.2018.08.005

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN： 0003-4266            Impact factor:   2.478


× No keyword cloud information.
  5 in total

1.  The Potential Link between Gut Microbiota and Serum TRAb in Chinese Patients with Severe and Active Graves' Orbitopathy.

Authors:  Ting-Ting Shi; Lin Hua; Hua Wang; Zhong Xin
Journal:  Int J Endocrinol       Date:  2019-12-18       Impact factor: 3.257

2.  Therapeutic Effect of α-MSH in Primary Cultured Orbital Fibroblasts Obtained from Patients with Thyroid Eye Disease.

Authors:  Pei-Wen Cheng; Pei-Jhen Tsai; Ming-Hong Tai; Youn-Shen Bee
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

3.  Diffusion Tensor Imaging Technology to Quantitatively Assess Abnormal Changes in Patients With Thyroid-Associated Ophthalmopathy.

Authors:  Li Rui; Li Jing; Wang Zhenchang
Journal:  Front Hum Neurosci       Date:  2022-02-04       Impact factor: 3.169

4.  The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves' orbitopathy.

Authors:  Ru-Xuan Zhao; Ting-Ting Shi; Sha Luo; Yun-Fu Liu; Zhong Xin; Jin-Kui Yang
Journal:  Endocr Connect       Date:  2022-02-09       Impact factor: 3.335

5.  Disrupted Spontaneous Neural Activity in Patients With Thyroid-Associated Ophthalmopathy: A Resting-State fMRI Study Using Amplitude of Low-Frequency Fluctuation.

Authors:  Wen Chen; Qian Wu; Lu Chen; Jiang Zhou; Huan-Huan Chen; Xiao-Quan Xu; Hao Hu; Fei-Yun Wu
Journal:  Front Hum Neurosci       Date:  2021-06-11       Impact factor: 3.169
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.